October is Breast Cancer Awareness Month. In support of this important cause, the Gingrich Foundation is pleased to announce The Breast Cancer Research Foundation as its charity of the month.
Breast cancer is the most common cancer in women. It is frequently diagnosed among women in 140 of 184 countries worldwide. In 2020, more than 2.3 million women were diagnosed with breast cancer globally. About 685,000 did not survive the disease.
Nearly 30 years ago, Evelyn H. Lauder decided to launch an initiative that would combat this tragic problem. She understood the vital need for increased breast cancer funding, and in 1993, established The Breast Cancer Research Foundation. She firmly believed in the growing need for clinical and genetic research devoted to the study of breast cancer, as well as the importance of supporting the women and families battling the disease.
Today, The Breast Cancer Research Foundation lives out its mission “to prevent and cure breast cancer by advancing the world’s most promising research.” BCRF is the highest-rated breast cancer charity in the U.S. – and is recognized as one of the most financially efficient nonprofits in the country. Currently, BCRF is also the largest private funder of both breast cancer and metastatic research in America.
Since its founding, The Breast Cancer Research Foundation has radically increased the number of projects that it funds. The organization supports 250 researchers based out of 14 countries on five continents.
This month BCRF announced its $47.5 million commitment to fund breast cancer research for 2021-2022. BCRF-funded research spans the entire spectrum of cancer – from studying the most basic biology of a cancer cell to developing innovative treatments and improving quality of life.
“This year, breast cancer became the most common cancer worldwide – surpassing lung cancer for the first time and impacting 2.3 million people,” said BCRF President & CEO Myra Biblowit. “At BCRF, we are tremendously grateful for our donors, partners, and volunteers who remained steadfast in their commitment to end breast cancer, even in the face of tremendous challenges, ensuring the continuation of lifesaving breakthroughs. Our global legion of investigators represents the very brightest minds in science working tirelessly to eradicate metastatic disease and prevent breast cancer entirely.”
BCRF is studying the root of all cancer cells, continuing efforts to understand inherited risk of cancer, advancing research on lifestyle and prevention strategies, and working to identify the best treatments for breast cancer – including during remission.
Thanks to The Breast Cancer Research Foundation’s investments in research, more lives have been saved, and breast cancer patients have received dramatically better care. Today, there are 3.8 million breast cancer survivors in the U.S.
We hope you will join Gingrich Foundation in supporting the Breast Cancer Research Foundation.
